Article tools
Author information

Articles

Glomerular Hemodynamics in Rats with Chronic Sodium Depletion: EFFECT OF SARALASIN

Robert W. Steiner, Bryan J. Tucker and Roland C. Blantz

Department of Medicine, University of California, San Diego, School of Medicine 92093, San Diego, California 92161 Veterans Administration Hospital, San Diego, California 92161

Published August , 1979

In chronic sodium depletion the glomerular filtration rate may be reduced, and alterations in proximal tubular function may contribute to the maintenance of antinatriuresis. Measurements were made by micropuncture technique in superficial nephrons of the Munich-Wistar rat of (a) the determinants of glomerular filtration rate, (b) peritubular capillary hydrostatic and oncotic pressure, and (c) proximal tubular fractional and absolute reabsorption in both a control group (group 1, n = 12) and a group of chronically sodium-depleted rats (group 2, n = 12). Single nephron filtration rate (sngfr) was 37.2±1.2 in group 1 and 31.6±1.0 nl/min/g kidney wt (P < 0.05) in group 2. Of the factors potentially responsible for the observed reduction in sngfr, there was no change in systemic oncotic pressure or the transglomerular hydrostatic pressure gradient. Sngfr was lower in group 2 because of both a reduced single nephron plasma flow (rpf) (128±6 vs. 112±5 nl/min per g kidney wt, P < 0.05) and additionally to a decrease in the glomerular permeability coefficient, LpA, from a minimum value of 0.105±0.012 in group 1 to 0.054±0.01 nl/s per g kidney wt per mm Hg (P < 0.01) after chronic sodium depletion. There was no difference in fractional proximal tubular reabsorption between group 1 and group 2. Absolute proximal reabsorption (APR) was reduced from 20.8±1.3 in group 1 to 16.3±0.9 nl/min per g kidney wt in group 2.

The role of angiotensin II (AII) in maintaining glomerular and proximal tubular adaptations to chronic sodium depletion was assessed in subsets of groups 1 and 2 by the infusion of the AII antagonist Saralasin at a rate of 1 μg/kg per min. In group 1 rats, Saralasin had no effect on sngfr, rpf, or LpA, because animals remained at filtration pressure equilibrium. In group 2 rats, AII blockade was associated with an increase in sngfr from 31.6±1.0 to 37.1±1.7 nl/min per g kidney wt (P < 0.01). Rpf increased during Saralasin infusion solely as a result of a decrease in afferent arteriolar resistance from 21.7±2.3 to 15.2±2.3 109 dyn-s-cm−5 (P < 0.01). Saralasin infusion did not affect the reduced LpA in group 2, as LpA remained 0.056±0.02 nl/s per g kidney wt per mm Hg and rats remained disequilibrated. In spite of the increase in sngfr in group 2, AII antagonism further decreased APR to 13.1±1.5 (P < 0.01). Distal delivery therefore, increased from a control value of 15.3±1.3 to 24.3±1.5 nl/min per g kidney wt (P < 0.01).

In conclusion, both a decrease in LpA and a reduction in rpf were major factors mediating the decrease in glomerular filtration rate observed in chronic sodium depletion. Saralasin infusion revealed a significant effect of AII on rpf and afferent arteriolar resistance in chronic sodium depletion, but no effect of AII on either efferent arteriolar resistance or the decrease in LpA could be demonstrated. Saralasin had no effect in rats that were not chronically sodium depleted. In group 2 rats AII antagonism reduced APR even though sngfr increased, suggesting an influence of AII on proximal reabsorption. The marked changes observed during Saralasin infusion in the chronically sodium-depleted rat reveal important modifying effects of endogenously generated AII on both the glomerulus and proximal tubule.

Browse pages

Click on an image below to see the page. View PDF of the complete article


Articles that cite this article:

Cellular expression of angiotensin type-1 receptor mRNA in the kidney
Björn Meister, Andrea Lippoldt, Bernd Bunnemann, Tadashi Inagami, Detlev Ganten, Kjell Fuxe
Kidney Int 44(2):331. doi:10.1038/ki.1993.248 [CrossRef]

SYMPATHETIC CONTROL OF THE RENAL CIRCULATION
A. Bomzon
J Auton Pharmacol 3(1):37. doi:10.1111/j.1474-8673.1983.tb00495.x [CrossRef]

EFFECTS OF ANGIOTENSINS II AND III ON GLOMERULOTUBULAR BALANCE IN RATS
Peter J. Harris, Jialong Zhuo, Sandford L. Skinner
Clin Exp Pharmacol Physiol 14(6):489. doi:10.1111/j.1440-1681.1987.tb01505.x [CrossRef]

Indirect evidence against a role of the kinin system in the renal hemodynamic effect of captopril in the rat
Albert Mimran, Daniel Casellas, Madeleine Dupont
Kidney Int 18(6):746. doi:10.1038/ki.1980.193 [CrossRef]

A novel in vivo mechanism for angiotensin type 1 receptor regulation
Hideki Nishimura, Taiji Matsusaka, Agnes Fogo, Valentina Kon, Iekuni Ichikawa
Kidney Int 52(2):345. doi:10.1038/ki.1997.340 [CrossRef]

Internephron heterogeneity of filtration fraction and disparity between protein- and hematocrit-derived values
Bruce Jackson, Donald E Oken
Kidney Int 21(2):309. doi:10.1038/ki.1982.23 [CrossRef]

Role of mesangial cell contraction in adaptation of the glomerular tuft to changes in extracellular volume
Marlies Elger, Tatsuo Sakai, Wilhelm Kriz
Pflugers Arch 415(5):598. doi:10.1007/BF02583512 [CrossRef]

Angiotensin-II Biochemistry and Physiology: Update on Angiotensin-II Receptor Blockers
Martin A. Bermann, Mary F. Walsh, James R. Sowers
Cardiovasc Drug Reviews 15(1):75. doi:10.1111/j.1527-3466.1997.tb00325.x [CrossRef]

Nephron responses to converting enzyme inhibition in non-clipped kidney of Goldblatt hypertensive rat at normotensive pressures
Wann-Chu Huang, Cynthia A Jackson, L Gabriel Navar
Kidney Int 28(2):128. doi:10.1038/ki.1985.131 [CrossRef]

Contribution of the renin-angiotensin system to the control of intrarenal hemodynamics
L Gabriel Navar, L\[adot]szl⊙ Rosivall
Kidney Int 25(6):857. doi:10.1038/ki.1984.102 [CrossRef]

Effects of unclipping and converting enzyme inhibition on bilateral renal function in Goldblatt hypertensive rats
Wann-Chu Huang, L Gabriel Navar
Kidney Int 23(6):816. doi:10.1038/ki.1983.100 [CrossRef]

Angiotensin actions in the kidney: Renewed insight into the old hormone
Iekuni Ichikawa, Raymond C Harris
Kidney Int 40(4):583. doi:10.1038/ki.1991.249 [CrossRef]

Angiotensin II control of the renal microcirculation: Effect of blockade by saralasin
Michael Steinhausen, Helmut Kücherer, Niranjan Parekh, Stefan Weis, David L Wiegman, Karl-Rainer Wilhelm
Kidney Int 30(1):56. doi:10.1038/ki.1986.150 [CrossRef]

Role for angiotensin II in an overt functional proteinuria
Toshimasa Yoshioka, Tetsuya Mitarai, Valentina Kon, William M Deen, Helmut G Rennke, Iekuni Ichikawa
Kidney Int 30(4):538. doi:10.1038/ki.1986.219 [CrossRef]

Proximal nephron and renal effects of DuP 753, a nonpeptide angiotensin II receptor antagonist
Ming-Hong Xie, Fu-Ying Liu, Pancras C Wong, Pieter B M W M Timmermans, Martin G Cogan
Kidney Int 38(3):473. doi:10.1038/ki.1990.228 [CrossRef]

Renal functional reserve: Its significance in normal and salt depletion conditions
Bruno Memoli, Carmelo Libetta, Massimo Sabbatini, Giuseppe Conte, Domenico Russo, Umberto Giani, Domenico Capone, Vittorio E Andreucci
Kidney Int 40(6):1134. doi:10.1038/ki.1991.325 [CrossRef]

Glomerular immune injury in the rat: The influence of angiotensin II and α-adrenergic inhibitors
Roland C Blantz, Bryan J Tucker, Leslie C Gushwa, Örjan W Peterson, Curtis B Wilson
Kidney Int 20(4):452. doi:10.1038/ki.1981.161 [CrossRef]

Glomerular blood flow
Michael Steinhausen, Karlhans Endlich, David L Wiegman
Kidney Int 38(5):769. doi:10.1038/ki.1990.271 [CrossRef]

Renal hemodynamics and segmental tubular reabsorption in early type 1 diabetes
Thierry P Hannedouche, Alvimar G Delgado, Daze A Gnionsahe, Christian Boitard, Bernard Lacour, Jean-Pierre Grünfeld
Kidney Int 37(4):1126. doi:10.1038/ki.1990.95 [CrossRef]